Richard F. Wallman - 07 May 2021 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Richard F. Wallman
Issuer symbol
CRL
Transactions as of
07 May 2021
Net transactions value
$0
Form type
4
Filing time
10 May 2021, 17:47:09 UTC
Previous filing
14 May 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +355 +1.1% $0.000000 32,070 07 May 2021 Direct F1
transaction CRL Common Stock Award $0 +219 +0.68% $0.000000 32,289 07 May 2021 Direct F2
holding CRL Common Stock 6,050 07 May 2021 By Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $0 +1,151 $0.000000 1,151 07 May 2021 Common Stock 1,151 $342.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders.
F2 The grant was made in lieu of director service fees for the term commencing May 5, 2021. The restricted stock units vest upon the earlier of 5/7/2021, or the business day prior to the Company's next annual meeting of shareholders.
F3 The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders.